본문 바로가기
KERD
논문KCI 등재

The Efficacy of Early Scheduled Follow-Up Endoscopic Retrograde Cholangiopancreatography after Common Bile Duct Stone Removal

이상우|이홍식|정성우|임형준|최재현|구자설|김창덕|유호상|Jin Nam Kim
거트앤리버 소화기연관학회협의회|2011.03|Gut and Liver|제5권 제1호|pp. 65-69

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Risk factorRecurrenceCholangitisEndoscopic retrograde cholangiopancreatographyCommon bile duct stone

초록

Background/Aims: To investigate the effi cacy of early scheduled follow-up endoscopic retrograde cholangiopancreatography (ERCP) after common bile duct (CBD) stone removal. Methods: Patients who underwent endoscopic CBD stone removal and who had at least one risk factor for stone recurrence were enrolled. Six months after complete clearance of the CBD, patients underwent follow-up ERCP at an ambulatory care center, irrespective of symptoms. Results: The incidence of symptoms and cholangitis at follow-up ERCP was signifi cantly lower in Group A (ERCP at 6 months after stone removal) than that in Group B (ERCP at >6 months) (14.3%vs 71.4%, p=0.00; 9.5% vs 33.3%, p=0.02, respectively). However, the recurrence rates of CBD stones were not different between Groups A and B (33.3% vs 47.6%). When comparing the subgroups, Group AR (stone recurrence in Group A)displayed signifi cantly fewer symptoms and lesser cholangitis and spent fewer days in the hospital than did Group BR (stone recurrence in Group B) (21.4% vs 70%, p=0.02; 14.3% vs 60%, p=0.02; 2.43±1.87 vs 6.10±3.35, p=0.00, respectively). Conclusions: Our data suggest that, irrespective of symptoms, early scheduled follow-up ERCP for patients who are at a high risk of recurrence is effective and safe.

Abstract

Background/Aims: To investigate the effi cacy of early scheduled follow-up endoscopic retrograde cholangiopancreatography (ERCP) after common bile duct (CBD) stone removal. Methods: Patients who underwent endoscopic CBD stone removal and who had at least one risk factor for stone recurrence were enrolled. Six months after complete clearance of the CBD, patients underwent follow-up ERCP at an ambulatory care center, irrespective of symptoms. Results: The incidence of symptoms and cholangitis at follow-up ERCP was signifi cantly lower in Group A (ERCP at 6 months after stone removal) than that in Group B (ERCP at >6 months) (14.3%vs 71.4%, p=0.00; 9.5% vs 33.3%, p=0.02, respectively). However, the recurrence rates of CBD stones were not different between Groups A and B (33.3% vs 47.6%). When comparing the subgroups, Group AR (stone recurrence in Group A)displayed signifi cantly fewer symptoms and lesser cholangitis and spent fewer days in the hospital than did Group BR (stone recurrence in Group B) (21.4% vs 70%, p=0.02; 14.3% vs 60%, p=0.02; 2.43±1.87 vs 6.10±3.35, p=0.00, respectively). Conclusions: Our data suggest that, irrespective of symptoms, early scheduled follow-up ERCP for patients who are at a high risk of recurrence is effective and safe.

참고문헌 (25)

  1. Hammarström LE, "Long-term follow-up after endoscopic treatment of bile duct calculi in cholecystectomized patients", World J Surg, 20, pp.272~276 (1996)
  2. Bergman JJ, "Long-term followup after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age", Gastrointest Endosc, 44, pp.643~649 (1996)
  3. Sugiyama M, "Follow-up of more than 10 years after endoscopic sphincterotomy for choledocholithiasis in young patients", Br J Surg, 85, pp.917~921 (1998)
  4. Prat F, "Biliary symptoms and complications more than 8 years after endoscopic sphincterotomy for choledocholithiasis", Gastroenterology, 110, pp.894~899 (1996)
  5. Sugiyama M, "Risk factors predictive of late complications after endoscopic sphincterotomy for bile duct stones: longterm (more than 10 years) follow-up study", Am J Gastroenterol, 97, pp.2763~2767 (2002)
  6. Keizman D, "Recurrent symptomatic common bile duct stones after endoscopic stone extraction in elderly patients", Gastrointest Endosc, 64, pp.60~65 (2006)
  7. Keizman D, "An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction", Surg Endosc, 20, pp.1594~1599 (2006)
  8. Ueno N, "Prognostic factors for recurrence of bile duct stones after endoscopic treatment by sphincter dilation", Gastrointest Endosc, 58, pp.336~340 (2003)
  9. Ohashi A, "Risk factors for recurrent bile duct stones after endoscopic papillary balloon dilation: long-term follow-up study", Dig Endosc, 21, pp.73~77 (2009)
  10. 천영국, "Identification of risk factors for stone recurrence after endoscopic treatment of bile duct stones", EUROPEAN JOURNAL OF GASTROENTEROLOGY HEPATOLOGY, 18(5), pp.461~464, LIPPINCOTT WILLIAMS WILKINS
  11. Costamagna G, "Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence", Endoscopy, 34, pp.273~279 (2002)
  12. Kim DI, "Risk factors for recurrence of primary bile duct stones after endoscopic biliary sphincterotomy", Gastrointest Endosc, 54, pp.42~48 (2001)
  13. Lai KH, "Do patients with recurrent choledocholithiasis after endoscopic sphincterotomy benefit from regular follow-up", Gastrointest Endosc, 55, pp.523~526 (2002)
  14. Kohn GP, "Endoscopic management of recurrent primary bile duct stones", ANZ J Surg, 78, pp.579~582 (2008)
  15. Bergman JJ, "Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones", Lancet, 349, pp.1124~1129 (1997)
  16. Ochi Y, "Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones", J Gastroenterol Hepatol, 14, pp.90~96 (1999)
  17. Arnold JC, "Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study", Endoscopy, 33, pp.563~567 (2001)
  18. Fujita N, "Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial", Gastrointest Endosc, 57, pp.151~155 (2003)
  19. Disario JA, "Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones", Gastroenterology, 127, pp.1291~1299 (2004)
  20. Tanaka S, "Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: longterm outcomes in a prospective randomized controlled trial", Gastrointest Endosc, 59, pp.614~618 (2004)
  21. Barkun AN, "Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group", Ann Surg, 220, pp.32~39 (1994)
  22. Irie H, "Pitfalls in MR cholangiopancreatographic interpretation", Radiographics, 21, pp.23~37 (2001)
  23. Mehta SN, "Magnetic resonance cholangiopancreatography", Gastrointest Endosc Clin N Am, 7, pp.247~270 (1997)
  24. Geenen DJ, "The role of surveillance endoscopic retrograde cholangiopancreatography in preventing episodic cholangitis in patients with recurrent common bile duct stones", Endoscopy, 30, pp.18~20 (1998)
  25. Sugiyama M, "Endoscopic retreatment of recurrent choledocholithiasis after sphincterotomy", Gut, 53, pp.1856~1859 (2004)

관련 논문AI추천

Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones천영국, Jung-Hye Choi, Tae-Yoon Lee대한내과학회 · The Korean Journal of Internal Medicine2021 · 제36권 제1호Recurrence of Bile Duct Stones after Endoscopic Papillary Large Balloon Dilation Combined with Limited Sphincterotomy: Long-Term Follow-Up Study김국현, 김태년, Jung Hyun Rhu거트앤리버 소화기연관학회협의회 · Gut and Liver2012 · 제6권 제1호The Role of Endoscopic Biliary Drainage without Sphincterotomy in Gallstone Patients with Cholangitis and Suspected Common Bile Duct Stones Not Detected by Cholangiogram or Intraductal Ultrasonography궁현정, 김민진, 문정호, 박상흠, 이윤나, 이태훈, 이혜경, 최문환, 최서연, 최현종거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제3호Feasibility of Endoscopic Papillary Large Balloon Dilation in Patients with Difficult Bile Duct Stones without Dilatation of the Lower Part of the Extrahepatic Bile DuctAkito Iwasaki, Atsushi Nakajima, Kensuke Kubota, Kentaro Sakamaki, Kunihiro Hosono, Nobuyuki Matsuhashi, Takamitsu Sato, Toshio Fujisawa, Yuji Fujita, Yusuke Sekino거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제1호Twenty-Second versus Sixty-Second Dilation Duration in Endoscopic Papillary Balloon Dilation for the Treatment of Small Common Bile Duct Stones: A Prospective Randomized Controlled Multicenter Trial정석, 권창일, 문종호, 방병욱, 송태준, 이태훈, 최현종, 한정호대한소화기내시경학회 · Clinical Endoscopy2015 · 제48권 제1호Cholecystectomy for Prevention of Recurrence after Endoscopic Clearance of Bile Duct Stones in Korea박승우, 박정엽, 방승민, 송명은, 송시영, 오탁근, 이동준, 정문재, 정재복연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제1호

이 간행물의 다른 논문 (19건)

Endoscopic Papillary Balloon Dilation for Removal of Choledocholithiasis: Indications, Advantages, Complications, and Long-Term Follow-Up Results정재복, Joo Won Chungpp. 1-14Current Limitations and Potential Breakthroughs for the Early Diagnosis of Hepatocellular Carcinoma김명진pp. 15-21Probiotic Fermented Milk Containing Dietary Fiber Has Additive Effects in IBS with Constipation Compared to Plain Probiotic Fermented MilkSoon Im Kim, Sung Chul Choi, Jong Chul Rhee, Hee Jung Son, Poong-Lyul Rhee, Jae J. Kim, 장동경, 심기현, 김범진, Seok Nam Park, Young Sil Hanpp. 22-28Anxiety, Depression and Quality of Life in Patients with Irritable Bowel SyndromeHyun Sun Cho, 임철현, 정윤경, 김상우, 이인석, 정인식, 조유경, 박재명, 최명규pp. 29-36Infl iximab Therapy Impacts the Peripheral Immune System of Immunomodulator and Corticosteroid Naïve Patients with Crohn’s DiseaseKoji Kamikozuru, Kyoichi Kato, Shinichiro Kashiwamura, Naohisa Takeda, Masaki Iimuro, Risa Kikuyama, Ken Fukunaga, Yoko Yokoyama, Hiroto Miwa, Takayuki Matsumoto, Nobuyuki Hida, Yoshio Ohda, Koji Yoshidapp. 37-45
원문 보기